(168) Milnacipran has low potential for drug-drug interaction von Periclou, A, Coutts, S, Rao, S, Palmer, R

Volltext

NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leu... von PERICLOU, A. P, AVRAMIS, V. I

Volltext

Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose oflevomilnacipran extended-release capsule in humans von Chen L, Greenberg WM, Brand-Schieber E, Wangsa J, Periclou A, Ghahramani P

Volltext

Population Pharmacodynamics of LY231514 in Patients With Cancer von Periclou, A.P., Ouellet, D., Johnson, R.D., Woodworth, J.M., Lalonde, R.L.

Volltext

Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil von Periclou, Antonia P, Ventura, Daniel, Sherman, Tyler, Rao, Niranjan, Abramowitz, Wattanaporn T

Volltext

Synergistic Combinations of Nucleoside Analog Drugs with Other Drugs Induce Greater Apoptosis in Human Leukemic T-Cells von Nandy, Partha, Periclou, Antonia P., Avramis, Vassilios I.

Volltext

Single Therapeutic Doses of Atogepant Are Not Associated With a Clinically Relevant Drug-Drug Interaction When Coadministered With Acetaminophen or Naproxen (1145) von Jakate, Abhijeet, Boinpally, Ramesh, Butler, Matthew, Periclou, Antonia

Volltext

Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans von Jakate, Abhijeet, Boinpally, Ramesh, Butler, Matthew, Lu, Kaifeng, McGeeney, Danielle, Periclou, Antonia

Volltext

Atogepant and sumatriptan: no clinically relevant drug–drug interactions in a randomized, open-label, crossover trial von Boinpally, Ramesh, Jakate, Abhijeet, Butler, Matthew, Periclou, Antonia

Volltext

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine:... von Jakate, Abhijeet, Blumenfeld, Andrew M., Boinpally, Ramesh, Butler, Matthew, Borbridge, Lisa, Contreras‐De Lama, Janette, McGeeney, Danielle, Periclou, Antonia, Lipton, Richard B.

Volltext

Evaluation of the pharmacokinetic interaction and safety of ubrogepant coadministered with acetaminophen or nonsteroidal anti-inflammatory drugs: A randomized trial von Jakate, Abhijeet, Boinpally, Ramesh, Butler, Matthew, Lu, Kaifeng, Womack, Kristi, McGeeney, Danielle, Periclou, Antonia

Volltext

Effects of CYP3A4 and P-glycoprotein inhibition or induction on the pharmacokinetics of ubrogepant in healthy adults: Two phase 1, open-label, fixed-sequence, single-center, crosso... von Jakate, Abhijeet, Boinpally, Ramesh, Butler, Matthew, Ankrom, Wendy, Dockendorf, Marissa F, Periclou, Antonia

Volltext

A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance von Su, Shengfang, Kay, Gary, Hochadel, Thomas, Rojo, Jonathan, Christopher Stein, J., Boinpally, Ramesh, Periclou, Antonia

Volltext

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update” von Periclou, Antonia, Riccobene, Todd, Kapás, Margit, Laszlovszky, István

Volltext

Comment on: "Clinical Pharmacokinetics of Atypical Antipsychotics: An Update"/Reply von Periclou, Antonia, Riccobene, Todd, Kapás, Margit, Laszlovszky, István, Mauri, Massimo Carlo

Volltext

Levomilnacipran Pharmacokinetics in Healthy Volunteers Versus Patients with Major Depressive Disorder and Implications for Norepinephrine and Serotonin Reuptake Inhibition von Chen, Laishun, PhD, Greenberg, William M., MD, Gommoll, Carl, MS, O’Connor, Joann, PhD, Zukin, Stephen R., MD, Periclou, Antonia, PhD, Ghahramani, Parviz, PhD

Volltext

PHARMACOKINETICS OF MEMANTINE AND DONEPEZIL AFTER A SINGLE DOSE OF A ONCE-DAILY FIXED-DOSE COMBINATION CAPSULE OF MEMANTINE EXTENDED RELEASE AND DONEPEZIL IN TWO PHASE I TRIALS von Boinpally, Ramesh, Hofbauer, Robert, Chen, Laishun, Zukin, Stephen, Periclou, Antonia

Volltext

Preferential binding to dopamine D^sub 3^ over D^sub 2^ receptors by cariprazine in patients with schizophrenia using PET with the D^sub 3^/D^sub 2^ receptor ligand [^sup 11^C]-(+)... von Girgis, Ragy R, Slifstein, Mark, D'souza, Deepak, Lee, Yih, Periclou, Antonia, Ghahramani, Parviz, Laszlovszky, István, Durgam, Suresh, Adham, Nika, Nabulsi, Nabeel, Huang, Yiyun, Carson, Richard E, Kiss, Béla, Kapás, Margit, Abi-dargham, Anissa, Rakhit, Ashok

Volltext

Preferential binding to dopamine D.sub.3 over D.sub.2 receptors by cariprazine in patients with schizophrenia using PET with the D.sub.3/D.sub.2 receptor ligand [.sup.11C]--PHNO von Girgis, Ragy R, Slifstein, Mark, D'Souza, Deepak, Lee, Yih, Periclou, Antonia, Ghahramani, Parviz, Laszlovszky, Istvan, Durgam, Suresh, Adham, Nika, Nabulsi, Nabeel, Huang, Yiyun, Carson, Richard E, Kiss, Bela, Kapas, Margit, Abi-Dargham, Anissa, Rakhit, Ashok

Volltext

Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia von Palmer, Robert H., Periclou, Antonia, Banerjee, Pradeep

Volltext